5,9 Micronutrient density is non-negotiable
Explore literature discussions, model-system findings, and peptide research pathways
Growing healthcare infrastructure, expanding access to advanced therapies, and rising disposable incomes are enabling more patients to afford GLP-1 treatments
Issa, M.D., Ph.D., FAAD explores the emerging therapies dermatology APPs should be watching in bullous pemphigoid and pemphigus vulgaris, including: Type 2 inflammation and dupilumab B cells and autoantibody production The potential role of JAK-STAT signaling These evolving treatment conversations reflect the immunology-focused clinical education coming to Elevate-Derm Summer 2026
Important: If you have a sore on your lip that does not heal after two weeks, or if your lips are persistently swollen and painful, consult a healthcare provider